| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2017 | LNTH Lantheus Holdings, Inc. | Burgstahler David F | Director | Sell | 91,166 | $17.01 | $1,550,884.55 | -4.0% | |
| Aug 25, 2017 | SNY Sanofi | Sanofi | 10% Owner | Buy | 72,378 | $481.36 | $34,840,132.96 | - | |
| Aug 24, 2017 | TLPH Talphera, Inc. | Angotti Vincent J.56 | Chief Executive Officer | Buy | 15,000 | $3.00 | $45,000.00 | New | |
| Aug 24, 2017 | SNY Sanofi | Sanofi | 10% Owner | Buy | 166,415 | $480.93 | $80,033,622.17 | - | |
| Aug 24, 2017 | TLPH Talphera, Inc. | Edwards Mark G | Director | Buy | 5,000 | $3.02 | $15,100.00 | +2.2% | |
| Aug 23, 2017 | CPIX Cumberland Pharmaceuticals Inc | Bonner Michael | Chief Financial Officer | Buy | 500 | $6.72 | $3,360.00 | +3.3% | |
| Aug 23, 2017 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 5,000 | $1.85 | $9,248.32 | +0.9% | |
| Aug 22, 2017 | TLPH Talphera, Inc. | Palmer Pamela P | Chief Medical Officer | Buy | 10,000 | $2.95 | $29,487.00 | +2.5% | |
| Aug 22, 2017 | PCRX Pacira Biosciences, Inc. | Hastings Paul J75 | Director | Sell | 1,044 | $36.15 | $37,740.60 | -22.9% | |
| Aug 21, 2017 | BHC Bausch Health Companies Inc. | De Schutter Richard U | Director | Buy | 10,000 | $14.33 | $143,296.00 | +6.7% | |
| Aug 21, 2017 | PAHC Phibro Animal Health Corp | Bendheim Daniel M | Exec. VP, Corporate Strategy | Sell | 4,976 | $40.01 | $199,097.76 | -100% | |
| Aug 18, 2017 | PRGO Perrigo Co Plc | Farrington Thomas | EVP And CIO | Sell | 865 | $78.40 | $67,812.18 | -14.8% | |
| Aug 18, 2017 | IRWD Ironwood Pharmaceuticals Inc | Consylman Gina | Chief Accounting Officer | Sell | 207 | $14.34 | $2,968.38 | -0.4% | |
| Aug 16, 2017 | SUPN Supernus Pharmaceuticals, Inc. | Bhatt Padmanabh P.69 | Sr.vp Of Ip, CSO | Sell | 3,709 | $45.23 | $167,754.73 | -17.5% | |
| Aug 16, 2017 | EGRX Eagle Pharmaceuticals, Inc. | Meyers Pete A. | Chief Financial Officer | Buy | 350 | $55.45 | $19,406.38 | +100.0% | |
| Aug 16, 2017 | LNTH Lantheus Holdings, Inc. | Avista Capital Partners Gp, LLC | 10% Owner | Sell | 140,846 | $17.27 | $2,432,665.45 | -1.3% | |
| Aug 16, 2017 | PAHC Phibro Animal Health Corp | Bendheim Daniel M | Exec. VP, Corporate Strategy | Sell | 7,681 | $40.04 | $307,573.67 | -100% | |
| Aug 16, 2017 | LNTH Lantheus Holdings, Inc. | Burgstahler David F | Director | Sell | 140,846 | $17.27 | $2,432,665.45 | -1.3% | |
| Aug 15, 2017 | PCRX Pacira Biosciences, Inc. | Stack David M67 | CEO And Chairman | Sell | 28,885 | $36.37 | $1,050,547.45 | -18.1% | |
| Aug 15, 2017 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 10,000 | $1.61 | $16,100.00 | +3.6% | |
| Aug 15, 2017 | PCRX Pacira Biosciences, Inc. | Williams Kristen Marie76 | CAO And General Counsel | Sell | 3,461 | $36.75 | $127,191.75 | -14.0% | |
| Aug 15, 2017 | AKBA Akebia Therapeutics, Inc. | Dahan Michel59 | SVP, Chief Business Officer | Sell | 5,000 | $15.00 | $75,000.00 | -4.7% | |
| Aug 15, 2017 | EBS Emergent Biosolutions Inc. | Hauer Jerome M | Director | Sell | 10,776 | $35.83 | $386,149.34 | -36.6% | |
| Aug 15, 2017 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 10,000 | $14.81 | $148,084.00 | -14.8% | |
| Aug 14, 2017 | SNY Sanofi | Sanofi | 10% Owner | Buy | 350,000 | $35.50 | $12,425,000.00 | +9.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.